TR201909163T4 - Bir karbonik anhidraz inhibitörü içeren oftalmik farmasötik bileşim ve bunun hazırlanması için yöntem. - Google Patents

Bir karbonik anhidraz inhibitörü içeren oftalmik farmasötik bileşim ve bunun hazırlanması için yöntem. Download PDF

Info

Publication number
TR201909163T4
TR201909163T4 TR2019/09163T TR201909163T TR201909163T4 TR 201909163 T4 TR201909163 T4 TR 201909163T4 TR 2019/09163 T TR2019/09163 T TR 2019/09163T TR 201909163 T TR201909163 T TR 201909163T TR 201909163 T4 TR201909163 T4 TR 201909163T4
Authority
TR
Turkey
Prior art keywords
preparation
pharmaceutical composition
composition containing
carbonic anhydrase
anhydrase inhibitor
Prior art date
Application number
TR2019/09163T
Other languages
English (en)
Inventor
Karavas Evangelos
Koutris Eftmihios
Samara Vasiliki
Milouli Efstathia
Kontiza Ioanna
Koutri Ioanna
Original Assignee
Pharmathen Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmathen Sa filed Critical Pharmathen Sa
Publication of TR201909163T4 publication Critical patent/TR201909163T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Mevcut buluş, oküler hipertansiyon ve glokom tedavisinde kullanmak üzere tedavi edici bir şekilde etkili bir miktarda Brinzolamid veya oftalmolojik kabul edilebilir tuzlar ve poloksamer gibi etkili bir yüzey aktif madde miktarı içeren topikal uygulama için kararlı bir farmasötik formülasyon ile ilgilidir.
TR2019/09163T 2012-03-22 2013-03-08 Bir karbonik anhidraz inhibitörü içeren oftalmik farmasötik bileşim ve bunun hazırlanması için yöntem. TR201909163T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20120100173A GR1007906B (el) 2012-03-22 2012-03-22 Οφθαλμικο φαρμακευτικο σκευασμα περιεχον ενα αναστολεα καρβονικης ανυδρασης και μεθοδος για την παρασκευη αυτου

Publications (1)

Publication Number Publication Date
TR201909163T4 true TR201909163T4 (tr) 2019-07-22

Family

ID=47913366

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/09163T TR201909163T4 (tr) 2012-03-22 2013-03-08 Bir karbonik anhidraz inhibitörü içeren oftalmik farmasötik bileşim ve bunun hazırlanması için yöntem.

Country Status (18)

Country Link
US (1) US20150080385A1 (tr)
EP (1) EP2827838B1 (tr)
AU (1) AU2013234721A1 (tr)
CA (1) CA2866810C (tr)
CY (1) CY1122598T1 (tr)
DK (1) DK2827838T3 (tr)
ES (1) ES2731754T3 (tr)
GR (1) GR1007906B (tr)
HR (1) HRP20191151T1 (tr)
HU (1) HUE043906T2 (tr)
LT (1) LT2827838T (tr)
PL (1) PL2827838T3 (tr)
PT (1) PT2827838T (tr)
RS (1) RS58814B1 (tr)
SI (1) SI2827838T1 (tr)
TR (1) TR201909163T4 (tr)
WO (1) WO2013139444A1 (tr)
ZA (1) ZA201301665B (tr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6704400B2 (ja) * 2014-10-20 2020-06-03 センティス・ファーマ・プライヴェート・リミテッド 眼科用液剤
GR1009616B (el) * 2018-07-20 2019-10-11 Φαρματεν Α.Β.Ε.Ε. Οφθαλμικο φαρμακευτικο σκευασμα που περιεχει βρινζολαμιδη και τιμολολη και μεθοδος παρασκευης αυτου

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3740421A (en) * 1966-09-19 1973-06-19 Basf Wyandotte Corp Polyoxyethylene-polyoxypropylene aqueous gels
US6071904A (en) * 1996-12-11 2000-06-06 Alcon Laboratories, Inc. Process for manufacturing ophthalmic suspensions
PT1885336E (pt) * 2005-05-10 2009-05-07 Alcon Inc Formulações de suspensão compreendendo um princípio activo, um tensoactivo poloxâmero ou meroxapol e um glicol, sua utilização no fabrico de um medicamento para tratamento de distúrbios oftálmicos
WO2010099613A1 (en) * 2009-03-03 2010-09-10 Viva Pharmaceutical Inc. Plant extract compositions for prevention and treatment of influenza
EP2394637A1 (en) 2010-05-21 2011-12-14 Zaklady Farmaceutyczne Polpharma SA Process for obtaining sterile brinzolamide suspensions
WO2013025696A1 (en) * 2011-08-15 2013-02-21 Teva Pharmaceutical Industries Ltd. Ophthalmic formulations and processes for their preparation

Also Published As

Publication number Publication date
EP2827838B1 (en) 2019-03-27
CY1122598T1 (el) 2021-01-27
DK2827838T3 (da) 2019-07-01
RS58814B1 (sr) 2019-07-31
PL2827838T3 (pl) 2019-09-30
ZA201301665B (en) 2013-12-23
GR1007906B (el) 2013-05-30
HUE043906T2 (hu) 2019-09-30
AU2013234721A1 (en) 2014-10-30
SI2827838T1 (sl) 2019-07-31
US20150080385A1 (en) 2015-03-19
PT2827838T (pt) 2019-06-05
LT2827838T (lt) 2019-05-10
WO2013139444A1 (en) 2013-09-26
CA2866810C (en) 2021-04-06
HRP20191151T1 (hr) 2019-10-04
EP2827838A1 (en) 2015-01-28
CA2866810A1 (en) 2013-09-26
ES2731754T3 (es) 2019-11-18

Similar Documents

Publication Publication Date Title
EA201690223A1 (ru) Ингибиторы фактора в комплемента на основе производных пиперидинилиндола и их применение
EA201492290A1 (ru) Составы и способы для вагинальной доставки антипрогестинов
EA201592250A1 (ru) Пиразолопирролидиновые производные и их применение в лечение заболеваний
EA202090860A1 (ru) Аналоги тиадиазола и способы лечения состояний, связанных с дефицитом smn
EA201590053A1 (ru) Модуляторы пути системы комплемента и их применение
PH12014502041A1 (en) Heterocyclyl compounds as mek inhibitors
EA201590371A1 (ru) 1,4-дизамещенные аналоги пиридазина и способы лечения связанных с дефицитом smn состояний
EA201591003A1 (ru) Производные бороновой кислоты и их терапевтическое применение
EA201592256A1 (ru) Производные имидазопирролидинона и их применение при лечении заболеваний
EA201391285A1 (ru) Производные тетрагидрохинолина, полезные в качестве ингибиторов бромодомена
EA201592255A1 (ru) Производные пиразолопирролидин-4-она в качестве ингибиторов вет и их применение при лечении заболевания
EA201490471A1 (ru) Пиридазиноновые соединения и их применение в качестве ингибиторов daao
BR112015009228A8 (pt) Formulação farmacêutica líquida estéril e forma de dosagem intraocular oftálmica líquida estéril para injeção
EA201200618A1 (ru) Производные хроменона с антиопухолевой активностью
UA106636C2 (uk) Морфолінотіазоли як позитивні алостеричні модулятори альфа 7
EA201492287A1 (ru) Дейтерированные производные руксолитиниба
EA201591499A1 (ru) Замещенные бисфенилбутановые производные фосфоновой кислоты в качестве ингибиторов nep (нейтральная эндопептидаза)
EA201490599A1 (ru) Соединения триазолопиридина в качестве ингибиторов фосфодиэстеразы pde10a
EA201691490A1 (ru) Фармацевтическая композиция, содержащая бринзоламид
EA201490222A1 (ru) Комбинированные составы на основе дарунавира
EA201401259A1 (ru) Фторированные мостиковые производные спиро[2,4]гептана в качестве агонистов рецептора alx
EA201490223A1 (ru) Составы на основе дарунавира
EA201400064A1 (ru) Офтальмологическая фармацевтическая композиция для местного применения, которая содержит регорафениб
EA201490573A1 (ru) Соединение бензотиазолона
GR1008483B (el) Οφθαλμικη φαρμακευτικη συνθεση και μεθοδος για την παρασκευη αυτης